Design and Discovery of Novel, Potent Pyrazinone-Based Thrombin Inhibitors with a Solubilizing Amino P1-P2-Linker

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 5, 2006-07 ,pp. : 289-292

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Hepatitis C Virus NS3.4A Protease: P2 Proline Variants

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 7, 2005-01 ,pp. : 497-502

Bentham Science Publishers

Access to resources Recommend Favorite

Protease inhibitors - Part 3. Synthesis of non-basic thrombin inhibitors incorporating pyridinium-sulfanilylguanidine moieties at the P1 site

By Scozzafava A.   Briganti F.   Supuran C.T.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 11, 1999-11 ,pp. : 939-952

Elsevier

Access to resources Recommend Favorite

P1/P1' modified HIV protease inhibitors as tools in two new sensitive surface plasmon resonance biosensor screening assays

By Alterman M.   Sjobom H.   Safsten P.   Markgren P.-O.   Danielson U.H.   Hamalainen M.   Lofas S.   Hulten J.   Classon B.   Samuelsson B.   Hallberg A.  

European Journal of Pharmaceutical Sciences, Vol. 13, Iss. 2, 2001-05 ,pp. : 203-212

Elsevier

Access to resources Recommend Favorite

Development of Flavone Propargyl Ethers as Potent and Selective Inhibitors of Cytochrome P450 Enzymes 1A1 and 1A2

By  

Drug Metabolism Letters, Vol. 6, Iss. 4, 2012-12 ,pp. : 275-284

Bentham Science Publishers

Access to resources Recommend Favorite